research paper on pharmaceutical industry

Hot Topics in Pharmaceutical Research. In this virtual issue, we highlight some of the most impactful recent articles in the journal as reflected by citations in 2022. Highly cited articles provide insight into which research topics are attracting the most attention and reflect innovative new discoveries, or timely reviews and perspectives on ...

Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science. When a knowledge system importantly loses integrity, ceasing to provide the kinds of trusted knowledge expected of it, we can label this epistemic corruption. Epistemic corruption often occurs because the system has been co-opted for interests at odds with some ...

Pharmaceutical Research is an official journal of the American Association of Pharmaceutical Scientists, covering innovative research in drug discovery, development, evaluation, and regulatory approval.. Current emphasis of the journal includes: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics ...

In response to the increasing number and breadth of innovation studies on the pharmaceutical industry, we mapped the literature to show the trends in recent research and to indicate areas for further research. In the first phase, we analyzed articles on the pharmaceutical industry published in innovation journals. We used these articles' textual and citation data and applied hybrid cluster ...

Recognizing these headwinds, AI/ML techniques are appealing to the pharmaceutical industry due to their automated nature, predictive capabilities, and the consequent expected increase in efficiency. ML approaches have been used in drug discovery over the past 15-20 years with increasing sophistication.

3 LITERATURE REVIEW 3.1 Sustainability in the pharmaceutical industry. While certain dimensions of sustainability are inherent to pharmaceutical corporations, given that their products increase the health and well-being of people, other aspects such as the environmental impact of drugs across their life-cycle, inequality in access to medicines, as well as unethical sales practices are topics ...

1. Introduction. In the past few decades, the pharmaceutical industry has been limited by the extent of cutting-edge research in pharmaceutical sciences, because the development of new drugs is a long and complex process accompanied by high risks and high costs [1], [2].In other words, the current field of drug research and development (R&D) requires significant productivity improvements to ...

Pharmaceutics is the scientific discipline concerned with the process of creating the dosage form (such as a pill for oral administration or a powder for intravenous injection) of a therapeutic ...

The Pharmaceutical Research and Manufacturers of America (PhRMA; www.phrma.org) reported that annualized savings from biosimilars reached $6.5 billion in 2020, with average biosimilar sales prices ...

Over the past decade, artificial intelligence (AI) and machine learning (ML) have become the breakthrough technology most anticipated to have a transformative effect on pharmaceutical research and development (R&D). This is partially driven by revolutionary advances in computational technology and the parallel dissipation of previous constraints to the collection/processing of large volumes of ...

The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health implications. In this paper we develop an evolutionary, agent-based model of the pharmaceutical industry to explore the impact of different configurations of the patent system upon innovation and competition.

Dennis Byrski & Fabian Gaessler & Matthew J. Higgins, 2022. "Market Size and Research: Evidence from the Pharmaceutical Industry," Academy of Management Proceedings, vol 2022 (1). Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings among ...

This report examines research and development (R&D) by the pharmaceutical industry. Spending on R&D and Its Results. Spending on R&D and the introduction of new drugs have both increased in the past two decades. In 2019, the pharmaceutical industry spent $83 billion dollars on R&D. Adjusted for inflation, that amount is about 10 times what the ...

Overall, the research agenda aligns with the principles of Organization Theory by focusing on the impact of digital transformation on various aspects of organizational functioning and addressing key challenges and opportunities in adapting to the digital landscape within the pharmaceutical industry. Future research shall therefore pursue these ...

The pharmaceutical industry plays an essential role in the financial development and social care of any society (Singh et al., 2016).It has been defined by Shah (2004) as a complex industry concerned with the invention, evolution, and production of medicines and remedies. Indeed, improvements in the pharmaceutical industry and suitable supply have ensured that people can access medications ...

Various classifications for research designs and methods used in pharmacy practice have been used in the literature. The following are some of the approaches for the classification of research designs: 1. Classification based on time orientation: Retrospective vs. prospective designs. a.

The significant surge in pharmaceutical mergers and acquisitions (M&A), averaging a 50% year-to-year increase over the last decade, has drawn concerns regarding its potential impact on consumers. Claims made by pharmaceutical companies suggest M&A, by increasing synergies, will cause innovation to increase and the firm to become more efficient ...

Space limitations confine this literature review to all original research papers pertinent to the drug supply chain which were presented at the 2021 AEA-ASSA convention. ... Gandhi A, Vasserman S. Bargaining and international reference pricing in the pharmaceutical industry. Paper presented at the 2021 virtual annual meeting of the Allied ...

The overarching structure of the contemporary pharmaceutical sector commences with the discoveries of drugs. It advances through preclinical and clinical trials, pharmaceutical manufacturing, and ...

pharmaceuticals market in India is expected to grow. at CAGR of ~16% and reach USD 55 billion by 2020. Additionally, by 2020, India will be amongst top ten. pharma markets in terms of absolute ...

The pharmaceutical industry devoted $83 billion to R&D expenditures in 2019. Those expenditures covered a variety of activities, including discovering and testing new drugs, developing incremental innovations such as product extensions, and clinical testing for safety-monitoring or marketing purposes.

Competition in the global pharmaceutical industry is driven by scientific knowledge rather than manufacturing know-how and a company's success will be largely dependent on its R&D efforts. Therefore, investments in R&D in the drug industry are very high as a percentage of total sales; reports suggest that it could be as much as 15% of the sale.

A new e-beam application in the pharmaceutical industry. NASA Astrophysics Data System (ADS) Sadat, Theo; Malcolm, Fiona. 2005-10-01. The paper presents a new electron beam application in the pharmaceutical industry: an in-line self-shielded atropic transfer system using electron beam for surface decontamination of products entering a pharmaceutical filling line.

The paper makes considerations about the role of the ethical code on building strong value-driven cultures as tool of corporate responsibility in the pharmaceutical industry. The aim is to demonstrate how difficult is the coherence between the values declared in the code and the effective behavior when the corporate ethical culture fails.

Many societies receive funding from pharmaceutical companies to support their research, educational, and academic activities. 1 However, financial relationships with pharmaceutical companies could introduce biases in decision-making and recommendations endorsed by societies. 2 It is paramount for societies to manage financial relationships with ...

Technology mergers and acquisitions (M&A) in China's pharmaceutical industry have emerged in this complex policy and economic background. This paper conducts an empirical study from the dual perspectives of financial performance and innovation performance, based on unbalanced panel data of Chinese listed pharmaceutical firms from 2012-2022.